Literature DB >> 17945252

TIMP-3 deficiency accelerates cardiac remodeling after myocardial infarction.

Hai Tian1, Massimo Cimini, Paul W M Fedak, Svetlana Altamentova, Shafie Fazel, Ming-Li Huang, Richard D Weisel, Ren-Ke Li.   

Abstract

The activity of TIMP-3, a natural tissue inhibitor of matrix metalloproteinases (MMPs), is decreased in the failing heart. This study evaluated the response to coronary ligation of cardiac structure, function, and matrix remodeling in wild-type (WT) mice, and those deficient in TIMP-3 (timp-3(-/-)). The coronary artery was ligated in timp-3(-/-) and age-matched WT mice. At various time points over the following 28-day period, left ventricular structure and function (by echocardiography, pressure-volume measurements and morphometry), MMP levels and activity, blood vessel density, cell proliferation, apoptosis, matrix structure, and inflammatory cytokine levels were assessed in both groups. After ligation, mortality was significantly greater in timp-3(-/-) than in WT mice. Morphometry and echocardiography demonstrated no difference in heart size or function prior to ligation; however, the progression of left ventricular systolic dysfunction was accelerated in timp-3(-/-) mice at 7, 14 and 28 days after infarction compared to WT controls. Left ventricular dilatation, gelatinase MMP activity, and TNF-alpha levels were significantly greater in timp-3(-/-) than in WT mice at different times after ligation. By histological evaluation, timp-3(-/-) mice exhibited significantly increased blood vessel density, cell proliferation, and apoptosis in the infarct area, and reduced collagen content in the viable remote myocardium compared to WT mice at 7 and 14 days after ligation. TIMP-3 deficiency accelerated maladaptive cardiac remodeling after a myocardial infarction by promoting matrix degradation and inflammatory cytokine expression. This study supports further investigations to determine whether such remodeling could be reduced by augmenting TIMP-3 expression in the infarcted myocardium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17945252     DOI: 10.1016/j.yjmcc.2007.09.003

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  26 in total

Review 1.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

Review 2.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

3.  Matrix metalloproteinase therapy in heart failure.

Authors:  Francis G Spinale; Nikole M Wilbur
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-08

Review 4.  Tissue inhibitor of metalloproteinases (TIMPs) in heart failure.

Authors:  Linn Moore; Dong Fan; Ratnadeep Basu; Vijay Kandalam; Zamaneh Kassiri
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

5.  MT1-MMP-dependent remodeling of cardiac extracellular matrix structure and function following myocardial infarction.

Authors:  Gerald C Koenig; R Grant Rowe; Sharlene M Day; Farideh Sabeh; Jeffrey J Atkinson; Kenneth R Cooke; Stephen J Weiss
Journal:  Am J Pathol       Date:  2012-03-29       Impact factor: 4.307

6.  Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction.

Authors:  Vijay Kandalam; Ratnadeep Basu; Thomas Abraham; Xiuhua Wang; Ahmed Awad; Wei Wang; Gary D Lopaschuk; Nobuyo Maeda; Gavin Y Oudit; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

7.  Tissue inhibitor of metalloproteinase-2 gene delivery ameliorates postinfarction cardiac remodeling.

Authors:  Ravi Ramani; Kathleen Nilles; Gregory Gibson; Benjamin Burkhead; Michael Mathier; Dennis McNamara; Charles F McTiernan
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

8.  Low tissue inhibitor of metalloproteinases 3 and high matrix metalloproteinase 14 levels defines a subpopulation of highly invasive foam-cell macrophages.

Authors:  Jason L Johnson; Graciela B Sala-Newby; Yasmin Ismail; Concepción M Aguilera; Andrew C Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

Review 9.  Ventricular remodeling and function: insights using murine echocardiography.

Authors:  Marielle Scherrer-Crosbie; Baptiste Kurtz
Journal:  J Mol Cell Cardiol       Date:  2009-07-15       Impact factor: 5.000

Review 10.  Myocardial infarction remodeling that progresses to heart failure: a signaling misunderstanding.

Authors:  Alan J Mouton; Osvaldo J Rivera; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-03-30       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.